Denmark· DK-28101353089
Synarela
A nafarelin product containing nafarelinacetat, registered in Denmark by Pfizer ApS. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Nafarelin is registered in 12 of 19 countries.
Countries holding a registration under ATC H01CA02 (nafarelin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Nafarelin · ATC H01CA02
12 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Nafarelinacetat
- Manufacturer
- Pfizer ApS
- Country
- Denmark (DK)
- ATC code
- H01CA02
- ATC class
- Nafarelin
- Defined daily dose
- 0.4 mg, N
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101353089
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under H01CA02
Nafarelin, as other registers publish it.
- United StatesSynarelPfizer Laboratories Div Pfizer Inc
- NorwaySynarelPfizer
- CzechiaSYNARELPfizer, spol. s r.o., Praha
- CanadaSYNARELPFIZER CANADA ULC
- CzechiaSYNARELPfizer, spol. s r.o., Praha
- FranceSYNAREL 0,2 mg/dose, solution pour pulvérisation nasalePFIZER HOLDING FRANCE
- IrelandSynarel 200 micrograms/dose Nasal Spray SolutionPfizer Healthcare Ireland Unlimited Company
- United KingdomSynarel 200micrograms/dose nasal sprayPfizer Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5ff00c1-ab14-41ab-a362-91e14e9181e5 GET /v1/drugs/c5ff00c1-ab14-41ab-a362-91e14e9181e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "næsespray, opløsning",
"source": "dkma",
"strength": "200 mikrogram/dosis",
"auth_role": "DKMA",
"dk_drugid": "28101353089",
"substance": "Nafarelinacetat",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "33052"
}See everything about nafarelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.